Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott K Pruitt

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Trauma and Acute Care Surgery|July 19, 2019
My Dad the Renaissance ManScott K Pruitt
Annals of Surgical Oncology|September 8, 2006
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancerElizabeth G Grubbs, Zeinab Abdel-Wahab, Douglas S Tyler, et al.
Blood|February 11, 2012
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory functionJens Dannull, Tristan Schneider, Walter T Lee, et al.
American Journal of Surgery|November 18, 2004
Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanomaTomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
The Journal of Surgical Research|June 19, 2002
Enhanced dendritic cell antigen presentation in RNA-based immunotherapyMatthew F Kalady, Mark W Onaitis, Karen M Padilla, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 24, 2004
Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cellsMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
The Journal of Surgical Research|January 21, 2004
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicityMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
Surgery|August 30, 2003
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapyMark W Onaitis, Matthew F Kalady, Sirisha Emani, et al.
The Journal of Surgical Research|July 30, 2013
Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccinationChunrui Tan, Jens Dannull, Smita K Nair, et al.
Blood|September 15, 2007
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunityJens Dannull, Diem-Thu Lesher, Robert Holzknecht, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Trauma and Acute Care Surgery|July 19, 2019
My Dad the Renaissance ManScott K Pruitt
Annals of Surgical Oncology|September 8, 2006
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancerElizabeth G Grubbs, Zeinab Abdel-Wahab, Douglas S Tyler, et al.
Blood|February 11, 2012
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory functionJens Dannull, Tristan Schneider, Walter T Lee, et al.
American Journal of Surgery|November 18, 2004
Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanomaTomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
The Journal of Surgical Research|June 19, 2002
Enhanced dendritic cell antigen presentation in RNA-based immunotherapyMatthew F Kalady, Mark W Onaitis, Karen M Padilla, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 24, 2004
Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cellsMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
The Journal of Surgical Research|January 21, 2004
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicityMatthew F Kalady, Mark W Onaitis, Sirisha Emani, et al.
Surgery|August 30, 2003
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapyMark W Onaitis, Matthew F Kalady, Sirisha Emani, et al.
The Journal of Surgical Research|July 30, 2013
Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccinationChunrui Tan, Jens Dannull, Smita K Nair, et al.
Blood|September 15, 2007
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunityJens Dannull, Diem-Thu Lesher, Robert Holzknecht, et al.
Pageof 5